Aggravation of Generalized Epilepsies

Summary: Generalized epilepsies are treatable with a number of antiepileptic drugs (AEDs) that are effective in different seizure types and epilepsy syndromes. The mechanisms of action of these AEDs are incompletely understood but include inhibition of low‐threshold calcium currents and of voltage‐gated sodium channels and facilitation of GABAA receptor currents. The mechanisms of aggravation are also unknown but could include elevation of brain GABA, blockade of voltage‐gated sodium channels, and idiosyncratic toxicity reactions. Anecdotal reports suggest that aggravation of generalized epilepsy can occur with virtually all AEDs. The best‐documented examples are aggravation of absences by carbamazepine and aggravation of symptomatic generalized epilepsies by vigaba‐trin. Therefore, the physician must be constantly aware of the problem of aggravation of seizures by AEDs. With careful diagnosis of the epileptic syndrome and an awareness of the problem, aggravation of seizures can be minimized.

[1]  D. Chadwick,et al.  Standard Approach to Antiepileptic Drug Treatment in the United Kingdom , 1994, Epilepsia.

[2]  C. Panayiotopoulos,et al.  Juvenile Myoclonic Epilepsy: A 5‐Year Prospective Study , 1994, Epilepsia.

[3]  H. Gastaut,et al.  Tonic Status Epilepticus precipitated by Intravenous Benzodiazepine in Five Patients with Lennox‐Gastaut Syndrome , 1972, Epilepsia.

[4]  B. Findeis.  [Possibility for provoking grand mal series in ethosuximide therapy--2 case reports]. , 1990, Psychiatrie, Neurologie, und medizinische Psychologie.

[5]  B. Wilder,et al.  "BALTIC" MYOCLONUS EPILEPSY: HEREDITARY DISORDER OF CHILDHOOD MADE WORSE BY PHENYTOIN , 1983, The Lancet.

[6]  T. Kurashige,et al.  Proposal for Revised Classification of Epilepsies and Epileptic Syndromes , 1989, No to hattatsu = Brain and development.

[7]  O. Snead,et al.  Exacerbation of seizures in children by carbamazepine. , 1985, The New England journal of medicine.

[8]  C. Horn,et al.  Carbamazepine-exacerbated epilepsy in children and adolescents. , 1986, Pediatric neurology.

[9]  J. Pellock,et al.  Standard Approach to Antiepileptic Drug Treatment in the United States , 1994, Epilepsia.

[10]  M. Sperling,et al.  Absence Seizures and Carbamazepine in Adults , 1994, Epilepsia.

[11]  F Andermann,et al.  Human Epileptogenesis and Hypothalamic Hamartomas: New Lessons from an Experiment of Nature , 1997, Epilepsia.

[12]  A. Wyler,et al.  Cataplexy and monoamine oxidase deficiency in Norrie disease , 1996, Neurology.

[13]  P. Bittencourt,et al.  Anticonvulsant‐Induced Status Epilepticus in Lennox‐Gastaut Syndrome , 1981, Epilepsia.

[14]  S. Berkovic.  Adults with Epilepsy: Is Monotherapy the Only Answer? , 1997 .

[15]  N. Gordon.  Treatment of epilepsy with a‐ethyl‐a‐methylsuccinimide (P.M. 671) , 1961, Neurology.

[16]  F Andermann,et al.  Concepts of absence epilepsies , 1987, Neurology.

[17]  W. Shields,et al.  Myoclonic, atonic, and absence seizures following institution of carbamazepine therapy in children , 1983, Neurology.

[18]  D C Reutens,et al.  Idiopathic generalized epilepsy of adolescence , 1995, Neurology.

[19]  G. Fenichel,et al.  Diphenylhydantoin activated seizures , 1965, Neurology.

[20]  Joseph B. Green.  Exacerbation of Seizures in Children by Carbamazepine , 1987 .

[21]  M. Brodie,et al.  New antiepileptic drugs. , 1996, The New England journal of medicine.

[22]  O. Dulac,et al.  The potential for increasing seizure frequency, relapse, and appearance of new seizure types with vigabatrin. , 1993, Neurology.

[23]  Jorge Eslava‐Cobos,et al.  Experience with the International League Against Epilepsy Proposals for Classification of Epileptic Seizures and the Epilepsies and Epileptic Syndromes in a Pediatric Outpatient Epilepsy Clinic , 1989, Epilepsia.

[24]  P. Loiseau,et al.  Classification of Epilepsies and Epileptic Syndromes in Two Different Samples of Patients , 1991, Epilepsia.

[25]  R. Macdonald,et al.  Mechanisms of Action of Currently Prescribed and Newly Developed Antiepileptic Drugs , 1994, Epilepsia.

[26]  N. Lenn,et al.  Exacerbation generalized nonconvulsive seizures with ethosuximide therapy. , 1978, Archives of neurology.

[27]  R. Clancy,et al.  Paradoxical precipitation of tonic seizures by lorazepam in a child with atypical absence seizures. , 1988, Pediatric neurology.

[28]  F. Sharbrough,et al.  Movement Disorders Associated with the Use of Gabapentin , 1996, Epilepsia.

[29]  J. Ferrendelli.  Relating pharmacology to clinical practice: the pharmacologic basis of rational polypharmacy. , 1995, Neurology.

[30]  D. Janz,et al.  Epilepsy with impulsive petit mal (Juvenile Myoclonic Epilepsy) , 1985, Acta neurologica Scandinavica.

[31]  M. J. Brodie,et al.  Drug therapy : antiepileptic drugs , 1996 .

[32]  N. D. Rudolf,et al.  Clonazepam in the Treatment of Children with Intractable Seizures , 1977, Developmental medicine and child neurology.

[33]  P. Lerman,et al.  Seizures Induced or Aggravated by Anticonvulsants , 1986, Epilepsia.

[34]  B. Steinhoff,et al.  Temporary abolition of seizure activity by flumazenil in a case of valproate-induced non-convulsive status epilepticus , 1993, Seizure.

[35]  D. Vossler.  Exacerbation of seizures in Lennox-Gastaut syndrome by gabapentin. , 1996, Neurology.